Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_1
1
20%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (50.0%)
N/A1 (50.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completednot_applicable

Proteomic Study of Tears From Patients With a PAX6 Mutation

NCT05562115
completed

Detecting SARS-CoV-2 in Tears

NCT04526769
completedphase_1

Analyzing the Composition of Tears to Identify Cancer

NCT00574678
completed

Lacritin and Heparanase Levels in Human Tears After Laser Refractive Surgery

NCT01049724
completed

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

NCT00487643

Clinical Trials (5)

Showing 5 of 5 trials
NCT05562115Not Applicable

Proteomic Study of Tears From Patients With a PAX6 Mutation

Completed
NCT04526769

Detecting SARS-CoV-2 in Tears

Completed
NCT00574678Phase 1

Analyzing the Composition of Tears to Identify Cancer

Completed
NCT01049724

Lacritin and Heparanase Levels in Human Tears After Laser Refractive Surgery

Completed
NCT00487643

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

Completed

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5